Literature DB >> 3489582

Lack of effect of exogenous recombinant interleukin-2 on trauma-induced abnormalities in lymphocyte proliferation.

E Abraham, R F Regan, Y H Chang.   

Abstract

Injury impairs cell-mediated immune function by depressing mitogen-induced lymphocyte proliferation and decreasing interleukin-2 (IL-2) production. In this study, we examined the ability of exogenous, recombinant IL-2 to restore lymphocyte proliferation after trauma. Recombinant IL-2 was added to cultures of phytohemagglutinin (PHA)-stimulated peripheral blood mononuclear cells obtained from seven healthy volunteers and from 21 victims of accidental trauma. In comparison to the healthy group, lymphocyte proliferation was reduced approximately 20% in patients with minor and moderate injuries, and 50% in patients with severe injuries. The addition of recombinant IL-2 to PHA-stimulated lymphocytes from injured patients did not substantially improve cellular proliferation. These results suggest that the depressed response of lymphocytes to mitogen stimulation after trauma is not due to decreased IL-2 generation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489582     DOI: 10.1097/00003246-198610000-00002

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  Haemorrhage produces depressions in alloantigen-specific immune responses in the mouse through activation of suppressor T cells.

Authors:  Y H Chang; M Jagels; E Abraham
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

2.  Generation of functionally active suppressor cells by haemorrhage and haemorrhagic serum.

Authors:  E Abraham; Y H Chang
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

3.  The release of immunosuppressive factor(s) in young males following exercise.

Authors:  Ye Tian; Jinlei Nie; Tom K Tong; Julien S Baker
Journal:  Sensors (Basel)       Date:  2012-05-02       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.